Images List Premium Download Classic

Cholesterol

Cholesterol-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Precision medicine for cholesterol treatment
Kymab Limited
June 14, 2018 - N°20180162935

The invention relates to human targets of interest (toi), anti-toi ligands, kits compositions and method.. .
Composition and uses thereof
Arborvitae Health And Wellbeing Pty. Ltd.
June 07, 2018 - N°20180153970

The invention relates to compositions comprising pinus pinaster stem bark extract, papain, and aloe vera extract, and methods of manufacturing same. There are also described methods of treating or preventing a variety of conditions, including treating or preventing elevated blood glucose, pre-diabetes, type 2 diabetes, autoimmune diseases, reducing or decreasing inflammation, treating or preventing diseases characterised by elevated levels of inflammation, ...
Combination liposomal pharmaceutical formulations
Cureport, Inc.
June 07, 2018 - N°20180153806

Docetaxel and doxorubicin can be formulated in liposomal pharmaceutical compositions. In various embodiments, the pharmaceutical compositions include (i) a first liposome type comprising a first lipid layer comprising an unsaturated phospholipid, cholesterol or a cholesterol derivative, dc-cholesterol, a cationic lipid, and preferably a pegylated phospholipid, and a first active pharmaceutical ingredient (api) comprising docetaxel in the first lipid layer; and (...
Cholesterol Patent Pack
Download + patent application PDFs
Cholesterol Patent Applications
Download + Cholesterol-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Cholesterol-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for preparing broccoli protein peptide, broccoli protein peptide prepared therefrom and use thereof
Zhejiang Teley Biotechnology Co., Ltd.
May 31, 2018 - N°20180147248

Provided is a method for preparing a broccoli protein peptide. The method uses a broccoli protein as the raw material, and obtains a broccoli protein peptide powder through the steps of preprocessing, enzymatic hydrolysis, terminating enzymatic hydrolysis, separation, and drying and the like.
Biosensors for detecting cholesterol and oxldl in blood sample
May 17, 2018 - N°20180136190

The present invention provides biosensors for detecting cholesterol and oxldl in blood sample. The present invention relates to a paper-based colorimetric biosensor and an electrochemical biosensor each for detecting cholesterol and oxldl in blood sample.
Serum-free suspension system for lentiviral production
Life Technologies Corporation
May 17, 2018 - N°20180135077

A lentiviral vector production system comprises (a) a lentiviral culture supplement to control cell growth, (b) a transfection reagent comprising dhdms, dope, and cholesterol to increase transfection efficiency, (c) a lentiviral production enhancer comprising sodium propionate, sodium butyrate, and caffeine to boost lentiviral production, wherein the lentiviral vector production system is serum-free. A method of lentiviral vector production comprises using ...
Cholesterol Patent Pack
Download + patent application PDFs
Cholesterol Patent Applications
Download + Cholesterol-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Cholesterol-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Artificial sebum film and method of producing same
May 17, 2018 - N°20180133276

A method for producing an artificial sebum film is provided with in raw material component and relative ratio, 78.4%-2% of triglyceride, 1%-15% of wax and ester, 20%-35% of squalane, 0.1%-7% of free fatty acid, 0.1%-6% of phospholipid, 0.1%-10% of cholesterol ester, 0.1%-10% of cholesterol, 0.1%-10% of antioxidant and 0.1%-5% of cellular activity regulator. The invention modifies the proportion of raw ...
Enrichment methods for preparing tannic acid compositions
Syneurx International (taiwan) Corp.
May 17, 2018 - N°20180133237

Methods for preparing tannic acid-containing compositions (e.g., pharmaceutical compositions, nutraceutical compositions or medical food compositions), particularly those having enriched tannic acid populations with superior potency, purity and safety profile. Also provide herein are the tannic acid-containing compositions for use in inhibiting d-amino acid oxidase and/or for treating cns disorder and obesity disorders including diabetes, hyperglycemia, hyperlipidemia or hypercholesterolemia..
Novel cholesterol metabolite, 5-cholesten, 3beta-25-diol, disulfate (25hcds) for therapy of metabolic disorders, hyperlipidemia, diabetes, ...
Virginia Commonwealth University
May 10, 2018 - N°20180127457

5-cholesten, 3β,25-diol, disulfate (25hcds) has been found to be an authentic pparγ agonist and lxr antagonist, and is used for the therapy of lipid disorders and inflammatory diseases, including without limitation fatty liver, inflammatory bowel, and atherosclerotic diseases.. .
Ketoconazole enantiomer in humans
Cortendo Ab (publ)
May 10, 2018 - N°20180125841

Treatment of patients with the 2s,4r ketoconazole enantiomer or its pharmaceutically acceptable salts, and solvates is useful for reducing systemic inflammation and cholesterol levels and improving glycemic control.. .
Regulation of mir-33 micrornas in the treatment of cholesterol-related disorders
The General Hospital Corporation
May 03, 2018 - N°20180119148

Compositions comprising nucleic acid sequences that target mir-33 micrornas are described, together with uses of the same in the treatment of cholesterol-related disorders.. .
Peptide with anti-obesity and anti-diabetes activity and use thereof
Caregen Co., Ltd.
May 03, 2018 - N°20180118783

A peptide and a peptide complex of the present invention exhibit an anti-obesity effect by inhibiting fat accumulation and decomposing already accumulated fat, and exhibit an excellent effect with respect to diabetes by effectively reducing blood sugar. The peptide and the peptide complex of the present invention decrease the expression of pparγ, acc, and ap2, which are adipogenic ...
Methods of treating liver disease using indane acetic acid derivatives
T3d Therapeutics, Inc.
May 03, 2018 - N°20180117013

This invention describes the use of indane acetic acid derivatives which are dual ppar delta/gamma agonists for the treatment of liver diseases including one or more of the following: nafld (non alcoholic fatty liver disease), nash (non alcoholic steatohepatitis), farber's disease, aclf (acute-on-chronic liver failure), clf (chronic liver failure), polt-hcv-svr (post-orthotopic liver transplant due to hepatitis c virus infection ...
Cholesterol Patent Pack
Download + patent application PDFs
Cholesterol Patent Applications
Download + Cholesterol-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Cholesterol-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods for preventing cardiovascular events through proprotein convertase subtilisin kexin 9 (pcsk9) protein reduction
The Medicines Company
April 19, 2018 - N°20180104360

Method of lowering low-density lipoprotein cholesterol or preventing a cardiac event in a subject who has atherosclerotic cardiovascular disease or who is atherosclerotic cardiovascular disease risk equivalent, involving administering to the subject a prophylactically effective amount of an rnai agent. Also, a method of preventing development of atherosclerotic cardiovascular disease in a subject involving administering to the subject a prophylactically ...
Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use ...
Moreinx Ab
April 19, 2018 - N°20180104330

A nanoparticle comprising at least one sterol, e.g. Cholesterol and a component from quillaja saponaria molina (quilq) selected from quillaja saponin, characterized in that said nanoparticles do not comprise a phospholipid and in that the sterol molecule is bound by a hydrophobic bond between a hydroxyl group of the sterol and terpene moieties in a quil a micelle and ...
Viral gene therapy as treatment for cholesterol storage disease or disorder
Services
April 19, 2018 - N°20180104289

Provided herein are compositions and methods for the viral gene therapy (e.g., aav-directed gene therapy) of cholesterol storage diseases or disorders, such as niemann-pick disease, type c.. .
Compounds for the prevention and treatment of cardiovascular diseases
Resverlogix Corp.
April 19, 2018 - N°20180104245

The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein a-i (apoa-i), and their use for treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.. .
Dry powder formulation of azole derivative for inhalation
Galephar Pharmaceutical Research, Inc.
April 19, 2018 - N°20180104239

A spray dried-powder composition for inhalation comprising particles (x) containing (a) between 5 and 50% by weight of at least one azole derivative in amorphous state but not in crystalline structure and (b) at least one matricial agent to the composition selected from a group consisting of polyol such as sorbitol, mannitol and xylitol; a monosaccharides such as glucose and arabinose; disaccharide ...
Effects of apolipoprotein b inhibition on gene expression profiles in animals
Kastle Therapeutics, Llc
April 05, 2018 - N°20180094260

Antisense compounds, compositions and methods are provided for modulating the expression of apolipoprotein b. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding apolipoprotein b.
Compositions containing tannic acids and uses thereof
Syneurx International (taiwan) Corp.
April 05, 2018 - N°20180092935

Compositions (e.g., pharmaceutical compositions, nutraceutical compositions or medical food compositions) comprising tannic acids, particularly tannic acids which are d-amino acid oxidase inhibitor with superior potency, purity and safety profile; and uses thereof for treating cns disorder and obesity disorders including diabetes, hyperglycemia, hyperlipidemia or hypercholesterolemia.. .
Processes in the preparation of coconut meat based compositions and films
April 05, 2018 - N°20180092391

A dehydrated coconut meat based edible film, including its improvements and modifications, includes mainly of coconut meat wherein other fruit and vegetables are added as flavorings and enhancers. These coconut meat based films can be used as crepes, rolls, and or wraps, which are usually employed in wrapping any food such as fresh fruits, vegetables, salads, or cooked meat/fish, ...
Loading